Imeglimin Hydrochloride API is a pharmaceutical-grade oral antidiabetic agent indicated for the treatment of Type 2 Diabetes Mellitus (T2DM). It belongs to a novel class of glucose-lowering agents known as tetrahydrotriazines and acts by improving mitochondrial bioenergetics, enhancing insulin secretion, increasing insulin sensitivity, and reducing excessive hepatic glucose production.
Imeglimin Hydrochloride provides comprehensive glycemic control through multiple complementary mechanisms while preserving pancreatic β-cell function. It is widely formulated into oral tablet formulations and may be used as monotherapy or in combination with other antidiabetic medications.
Manufactured under WHO-GMP-certified facilities, our Imeglimin Hydrochloride API is produced using advanced manufacturing technologies to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes rigorous quality testing and is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Imeglimin Hydrochloride API is used in oral pharmaceutical formulations for the treatment of Type 2 Diabetes Mellitus and improving glycemic control.
Imeglimin Hydrochloride improves mitochondrial function, enhances insulin secretion, increases insulin sensitivity, and reduces hepatic glucose production to effectively lower blood glucose levels.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Imeglimin Hydrochloride API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp